Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1613-7671
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk ; day:14 ; month:8 ; year:2019 ; pages:1-13
Wiener klinische Wochenschrift ; (14.8.2019), 1-13
- Creator
-
Stühlinger, Markus C.
Weltermann, Ansgar
Staber, Philipp
Heintel, Daniel
Nösslinger, Thomas
Steurer, Michael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00508-019-1534-1
- URN
-
urn:nbn:de:101:1-2020010104054814135218
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stühlinger, Markus C.
- Weltermann, Ansgar
- Staber, Philipp
- Heintel, Daniel
- Nösslinger, Thomas
- Steurer, Michael
- SpringerLink (Online service)
Other Objects (12)
Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
Atrial fibrillation
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide
Causes of death in Irish Wolfhounds with atrial fibrillation and/or dilated cardiomyopathy
Causes of death in Irish Wolfhounds with atrial fibrillation and/or dilated cardiomyopathy
Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?
Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation
Cardioversion of atrial fibrillation
Schwerpunktthema Vorhofflimmern : = Atrial fibrillation
Cardioversion of atrial fibrillation
Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study
Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
Atrial fibrillation
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide
Causes of death in Irish Wolfhounds with atrial fibrillation and/or dilated cardiomyopathy
Causes of death in Irish Wolfhounds with atrial fibrillation and/or dilated cardiomyopathy
Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?
Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation
Cardioversion of atrial fibrillation
Schwerpunktthema Vorhofflimmern : = Atrial fibrillation
Cardioversion of atrial fibrillation
Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study
Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
Atrial fibrillation
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide
Causes of death in Irish Wolfhounds with atrial fibrillation and/or dilated cardiomyopathy
Causes of death in Irish Wolfhounds with atrial fibrillation and/or dilated cardiomyopathy
Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?
Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation
Cardioversion of atrial fibrillation
Schwerpunktthema Vorhofflimmern : = Atrial fibrillation
Cardioversion of atrial fibrillation